D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 89 Citations 25,408 221 World Ranking 183 National Ranking 92
Medicine D-index 73 Citations 20,989 176 World Ranking 13048 National Ranking 6889

Overview

What is he best known for?

The fields of study he is best known for:

  • Antibiotics
  • Bacteria
  • Internal medicine

George M. Eliopoulos mainly investigates Microbiology, Antibiotics, Staphylococcus aureus, Antibacterial agent and Vancomycin. His research in Microbiology intersects with topics in Daptomycin, Virulence and Linezolid. The Antibiotics study combines topics in areas such as Pseudomonas aeruginosa, Bacteria and Antimicrobial.

His research integrates issues of Glycopeptide and Bacteremia in his study of Staphylococcus aureus. His biological study spans a wide range of topics, including Logistic regression, Immunology, Imipenem, Intensive care unit and Cohort. His Vancomycin research integrates issues from Enterococcus faecalis, Internal medicine and Gentamicin.

His most cited work include:

  • The Sanford guide to antimicrobial therapy (945 citations)
  • Linezolid resistance in a clinical isolate of Staphylococcus aureus (857 citations)
  • Linezolid resistance in a clinical isolate of Staphylococcus aureus (857 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Microbiology, Antibiotics, Antibacterial agent, Antimicrobial and Vancomycin. His Microbiology research incorporates elements of Enterococcus faecalis and Staphylococcus aureus. George M. Eliopoulos has researched Antibiotics in several fields, including Internal medicine and Endocarditis.

George M. Eliopoulos usually deals with Antibacterial agent and limits it to topics linked to Minimum inhibitory concentration and Penicillin. His Antimicrobial study also includes fields such as

  • Pharmacology which intersects with area such as Erythromycin,
  • Drug resistance which is related to area like Antibiotic resistance. His study connects Bacteremia and Vancomycin.

He most often published in these fields:

  • Microbiology (98.51%)
  • Antibiotics (52.24%)
  • Antibacterial agent (45.90%)

What were the highlights of his more recent work (between 2006-2020)?

  • Microbiology (98.51%)
  • Staphylococcus aureus (31.72%)
  • Antibiotics (52.24%)

In recent papers he was focusing on the following fields of study:

George M. Eliopoulos mostly deals with Microbiology, Staphylococcus aureus, Antibiotics, Vancomycin and Daptomycin. George M. Eliopoulos is studying Fosfomycin, which is a component of Microbiology. His studies deal with areas such as Antibacterial agent, Gene and Point mutation as well as Staphylococcus aureus.

His work on Micrococcaceae as part of general Antibacterial agent research is frequently linked to RRNA Operon and 23S ribosomal RNA, bridging the gap between disciplines. His Antibiotics study integrates concerns from other disciplines, such as Antibacterial activity, Eperezolid, Potency and Piperazine. His work in Vancomycin addresses subjects such as Enterococcus faecium, which are connected to disciplines such as Antibiotic resistance, Amp resistance, Drug resistance, Teicoplanin and Telavancin.

Between 2006 and 2020, his most popular works were:

  • Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics. (221 citations)
  • Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics. (221 citations)
  • Whole Genome Characterization of the Mechanisms of Daptomycin Resistance in Clinical and Laboratory Derived Isolates of Staphylococcus aureus (158 citations)

In his most recent research, the most cited papers focused on:

  • Antibiotics
  • Bacteria
  • Internal medicine

George M. Eliopoulos spends much of his time researching Microbiology, Vancomycin, Staphylococcus aureus, Antibiotics and Virulence. His studies in Microbiology integrate themes in fields like Carbapenem-resistant enterobacteriaceae and Daptomycin. His work investigates the relationship between Daptomycin and topics such as Antibacterial agent that intersect with problems in Methicillin-resistant Staphylococcus aureus, Methicillin Susceptible Staphylococcus Aureus and Lipopeptide.

His Vancomycin research is multidisciplinary, relying on both Tigecycline and Enterococcus faecium. His studies examine the connections between Staphylococcus aureus and genetics, as well as such issues in Mutation, with regards to Hemolysin and Whole genome sequencing. He works mostly in the field of Virulence, limiting it down to topics relating to Acinetobacter baumannii and, in certain cases, Acinetobacter lwoffii, Neisseriaceae, Quorum sensing and Eukaryote.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Linezolid resistance in a clinical isolate of Staphylococcus aureus

Sotirios Tsiodras;Sotirios Tsiodras;Howard S Gold;Howard S Gold;George Sakoulas;George Sakoulas;George M Eliopoulos;George M Eliopoulos.
The Lancet (2001)

1224 Citations

Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

George Sakoulas;Pamela A. Moise-Broder;Jerome Schentag;Alan Forrest.
Journal of Clinical Microbiology (2004)

1195 Citations

The Sanford guide to antimicrobial therapy

David N. Gilbert;Robert C. Moellering;George M. Eliopoulos;Henry F. Chambers.
(2010)

1167 Citations

Emergence of Antibiotic-Resistant Pseudomonas aeruginosa: Comparison of Risks Associated with Different Antipseudomonal Agents

Yehuda Carmeli;Nicolas Troillet;George M. Eliopoulos;Matthew H. Samore.
Antimicrobial Agents and Chemotherapy (1999)

765 Citations

New β-Lactamases in Gram-Negative Bacteria: Diversity and Impact on the Selection of Antimicrobial Therapy

George M. Eliopoulos;Karen Bush.
Clinical Infectious Diseases (2001)

532 Citations

Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility.

L B Rice;S H Willey;G A Papanicolaou;A A Medeiros.
Antimicrobial Agents and Chemotherapy (1990)

503 Citations

Accessory Gene Regulator (agr) Locus in Geographically Diverse Staphylococcus aureus Isolates with Reduced Susceptibility to Vancomycin

George Sakoulas;George M. Eliopoulos;Robert C. Moellering;Christine Wennersten.
Antimicrobial Agents and Chemotherapy (2002)

494 Citations

Accessory Gene Regulator Group II Polymorphism in Methicillin-Resistant Staphylococcus aureus Is Predictive of Failure of Vancomycin Therapy

Pamela A. Moise-Broder;George Sakoulas;George M. Eliopoulos;Jerome J. Schentag.
Clinical Infectious Diseases (2004)

467 Citations

Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein.

Vance G. Fowler;George Sakoulas;Lauren M. McIntyre;Lauren M. McIntyre;Venkata G. Meka.
The Journal of Infectious Diseases (2004)

406 Citations

Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2.

Richard E. Person;Feng Qian Li;Zhijun Duan;Kathleen F. Benson.
Nature Genetics (2003)

383 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing George M. Eliopoulos

Michael J. Rybak

Michael J. Rybak

Eugene Applebaum College of Pharmacy and Health Sciences

Publications: 172

Ronald N. Jones

Ronald N. Jones

JMI Laboratories

Publications: 158

Arnold S. Bayer

Arnold S. Bayer

University of California, Los Angeles

Publications: 101

George Sakoulas

George Sakoulas

University of California, San Diego

Publications: 96

Cesar A. Arias

Cesar A. Arias

The University of Texas Health Science Center at Houston

Publications: 70

Louis B. Rice

Louis B. Rice

Brown University

Publications: 70

Helio S. Sader

Helio S. Sader

JMI Laboratories

Publications: 57

Michael R. Yeaman

Michael R. Yeaman

University of California, Los Angeles

Publications: 55

Anton Y. Peleg

Anton Y. Peleg

Monash University

Publications: 53

David M. Livermore

David M. Livermore

University of East Anglia

Publications: 49

Barbara E. Murray

Barbara E. Murray

The University of Texas at Austin

Publications: 47

Yan Q. Xiong

Yan Q. Xiong

University of California, Los Angeles

Publications: 47

Vance G. Fowler

Vance G. Fowler

Duke University

Publications: 45

David P. Nicolau

David P. Nicolau

Hartford Hospital

Publications: 44

Benjamin P. Howden

Benjamin P. Howden

University of Melbourne

Publications: 42

Eleftherios Mylonakis

Eleftherios Mylonakis

Brown University

Publications: 41

Trending Scientists

Zhi Liu

Zhi Liu

Shanghai University

Mohammad Tariqul Islam

Mohammad Tariqul Islam

National University of Malaysia

Ruggero Caminiti

Ruggero Caminiti

Sapienza University of Rome

Mamoun Muhammed

Mamoun Muhammed

Royal Institute of Technology

Masanobu Miyao

Masanobu Miyao

Kyushu University

Frank J. Slack

Frank J. Slack

Beth Israel Deaconess Medical Center

David B. Lank

David B. Lank

Simon Fraser University

Arie Altman

Arie Altman

Hebrew University of Jerusalem

Donald C. Rundquist

Donald C. Rundquist

University of Nebraska–Lincoln

P. Read Montague

P. Read Montague

Virginia Tech

Carsten K. W. De Dreu

Carsten K. W. De Dreu

University of Amsterdam

James E. Hoffman

James E. Hoffman

University of Delaware

Deanna Kerrigan

Deanna Kerrigan

Johns Hopkins University

Ulf Böckenholt

Ulf Böckenholt

Northwestern University

Something went wrong. Please try again later.